Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ablative techniques for hepatocellular carcinoma.

C C Barnett1, S A Curley

  • 1University of Texas M.D. Anderson Cancer Center, Houston, TX 77030-4095, USA.

Seminars in Oncology
|October 31, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vascular Resections for Pancreatic Ductal Adenocarcinoma: Vascular Resections for PDAC.

Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society·2020
Same author

Portal vein embolization improves rate of resection of extensive colorectal liver metastases without worsening survival.

The British journal of surgery·2013
Same author

Hepatectomy for recurrent colorectal liver metastases after radiofrequency ablation.

The British journal of surgery·2011
Same author

Bile duct complications of hepatic arterial infusion chemotherapy evaluated by helical CT.

Clinical radiology·2005
Same author

Hepatitis B or C virus serology as a prognostic factor in patients with hepatocellular carcinoma.

Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract·2002
Same author

Radiofrequency ablation of hepatocellular carcinoma.

Minerva chirurgica·2002
Same journal

A systematic scoping review of cancer-related anemia treatment: Comparative trial outcomes, current guidelines, and future perspectives.

Seminars in oncology·2026
Same journal

Steroid-induced tumor lysis syndrome in solid tumors: A case report and review of the literature.

Seminars in oncology·2026
Same journal

PSMA PET/CT staging in intermediate-risk prostate cancer: Toward risk-adapted implementation.

Seminars in oncology·2026
Same journal

Angiogenesis and the corresponding antiangiogenic therapy in gastroenteropancreatic neuroendocrine neoplasms.

Seminars in oncology·2026
Same journal

Post-translational regulation of steroidogenesis and its clinical relevance in hormone responsive cancers.

Seminars in oncology·2026
Same journal

Physics-informed machine learning for tumor microenvironment-responsive nanomedicine: Recent updates.

Seminars in oncology·2026
See all related articles

Hepatocellular carcinoma (HCC) resection is ideal but often not possible. Ablative therapies like radiofrequency ablation offer local tumor control for inoperable HCC patients.

Area of Science:

  • Hepatology
  • Oncology
  • Interventional Radiology

Background:

  • Hepatocellular carcinoma (HCC) is a primary liver cancer.
  • Surgical resection is the optimal treatment but is only feasible for a minority of patients due to factors like metastatic disease, vascular invasion, or poor liver function.
  • Inoperable patients require alternative treatment strategies.

Purpose of the Study:

  • To review current ablative techniques for hepatocellular carcinoma.
  • To discuss the indications, benefits, and limitations of these procedures.
  • To provide perspective on ablative therapies as treatment options for HCC.

Main Methods:

  • Review of current literature on ablative techniques for HCC.
  • Discussion of percutaneous ethanol injection (PEI), hepatic arterial chemoembolization, cryoablation, radiofrequency ablation (RFA), and microwave coagulation.

Related Experiment Videos

  • Analysis of indications, benefits, and limitations.

    • Main Results:

    • Ablative procedures offer local tumor control for inoperable HCC.
    • Techniques like PEI and RFA can potentially achieve long-term disease-free survival.
    • These methods minimize the loss of functioning hepatic tissue compared to resection.

    Conclusions:

    • Ablative therapies are crucial for managing inoperable hepatocellular carcinoma.
    • Understanding the specific indications, benefits, and limitations of each technique is vital.
    • These procedures represent important alternatives to resection for select HCC patients.